Financhill
Buy
62

RGA Quote, Financials, Valuation and Earnings

Last price:
$191.84
Seasonality move :
5.04%
Day range:
$189.87 - $193.94
52-week range:
$178.84 - $233.81
Dividend yield:
1.84%
P/E ratio:
17.86x
P/S ratio:
0.58x
P/B ratio:
1.17x
Volume:
1.2M
Avg. volume:
629.9K
1-year change:
3.13%
Market cap:
$12.7B
Revenue:
$22B
EPS (TTM):
$10.74

Earnings Data

Next earnings date for RGA
May 02
2025
Most recent earnings per share
$2.22
Missed by $3.04
(Feb 6/2025)
Consensus Estimate
$5.26
(Feb 6/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

RGA Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/02/2025 Q1 $5.7B -- -- $5.47 --
02/06/2025 Q4 $5.6B $5.2B $2.22 $5.26 -$3.04
10/31/2024 Q3 $5.4B $5.6B $2.33 $5.34 -$3.01
08/01/2024 Q2 $5.1B $4.9B $3.03 $5.09 -$2.06
05/02/2024 Q1 $4.6B $6.3B $3.16 $4.57 -$1.41
02/01/2024 Q4 $4.6B $4.9B $2.37 $4.46 -$2.09
11/02/2023 Q3 -- -- $4.29 $4.28 $0.01
08/03/2023 Q2 -- -- $3.05 $4.14 -$1.09
05/04/2023 Q1 -- -- $3.72 $3.78 -$0.06
02/02/2023 Q4 -- -- $4.30 $3.73 $0.57
11/04/2022 Q3 -- -- $4.19 $3.00 $1.19
08/04/2022 Q2 -- -- $2.92 $2.76 $0.16
05/05/2022 Q1 -- -- -$0.93 -$0.48 -$0.45
02/03/2022 Q4 -- -- $2.30 $0.79 $1.51
11/04/2021 Q3 -- -- -$0.32 $2.46 -$2.78
08/03/2021 Q2 -- -- $5.02 $1.96 $3.06
05/06/2021 Q1 -- -- $2.03 -$0.33 $2.36
02/08/2021 Q4 -- -- $1.94 $1.02 $0.92
11/05/2020 Q3 -- -- $3.12 $1.77 $1.35
08/04/2020 Q2 -- -- $2.48 -$0.85 $3.33
05/05/2020 Q1 -- -- -$1.41 $2.37 -$3.78
01/28/2020 Q4 -- -- $3.68 $3.66 $0.02
10/30/2019 Q3 -- -- $4.12 $3.50 $0.62
07/29/2019 Q2 -- -- $3.18 $3.42 -$0.24
04/29/2019 Q1 -- -- $2.65 $2.62 $0.03
01/28/2019 Q4 -- -- $1.72 $3.46 -$1.74
10/25/2018 Q3 -- -- $4.68 $3.27 $1.41
07/26/2018 Q2 -- -- $3.13 -- --
04/26/2018 Q1 -- -- $1.52 -- --
01/29/2018 Q4 -- -- $18.49 -- --
10/26/2017 Q3 -- -- $3.47 -- --
07/27/2017 Q2 -- -- $3.54 -- --
04/27/2017 Q1 -- -- $2.22 -- --
01/30/2017 Q4 -- -- $2.92 -- --
10/26/2016 Q3 -- -- $3.07 -- --
07/28/2016 Q2 -- -- $3.64 -- --
04/29/2016 Q1 -- -- $1.17 -- --
01/29/2016 Q4 -- -- $2.46 -- --
10/30/2015 Q3 -- -- $1.25 -- --
07/24/2015 Q2 -- -- $1.94 -- --
04/24/2015 Q1 -- -- $1.81 -- --

Reinsurance Group of America Earnings Questions

  • How Much did Reinsurance Group of America Generate in Revenue Last Quarter?

    Reinsurance Group of America reported $5.2B worth of top line sales in its most recent quarter.

  • Did Reinsurance Group of America Beat Earnings Last Quarter?

    Reinsurance Group of America announced earnings per share of $2.22 which represents a miss of analyst forecast a $5.26 per share.

  • Is Reinsurance Group of America Profitable?

    Reinsurance Group of America reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Reinsurance Group of America EPS Next Year?

    Reinsurance Group of America's earnings are forecast to grow from $10.73 per share to $22.95 per share next year representing an increase of 113.92%.

  • When is Reinsurance Group of America's Earnings Date?

    Reinsurance Group of America's next earnings date is May 2, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Amazon Stock Still Worth Staking On?
Is Amazon Stock Still Worth Staking On?

Amazon.com Inc (NASDAQ: AMZN) posted one of its strongest years…

Is Palantir a Good Stock to Buy?
Is Palantir a Good Stock to Buy?

Palantir Technologies (PLTR) stock soared to its highest level in…

Why Is Sportradar Stock Going Up?
Why Is Sportradar Stock Going Up?

Sportradar (NASDAQ:SRAD) should be on your radar for a stock…

Stock Ideas

Buy
55
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 36x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Sell
50
RGC alert for Mar 22

Regencell Bioscience Holdings [RGC] is up 27.82% over the past day.

Sell
36
VMI alert for Mar 22

Valmont Industries [VMI] is down 12.54% over the past day.

Buy
61
ALNY alert for Mar 22

Alnylam Pharmaceuticals [ALNY] is up 11.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock